Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Inhaled Nitric Oxide and Gentle Ventilation in the Treatment of Pulmonary Hypertension of the Newborn — a Single-Center, 5-Year Experience

Journal of Perinatology volume 22, pages 435–441 (2002)Cite this article

Abstract

OBJECTIVE: To evaluate the effect of inhaled nitric oxide (INO) in pulmonary hypertension of the newborn (PH) in a single center over 5 years using gentle ventilation (GV), without hyperventilation or induced alkalosis.

METHODS: Data from 229 consecutive infants with PH of varied etiology treated with INO and GV, and from 67 infants with meconium aspiration syndrome (MAS) and primary PH (PPHN) treated with GV alone were reviewed over a 5-year period (86% outborn). INO was initiated at 25 ppm when PH and severe hypoxemia persisted despite maximal optimal ventilation. Hyperventilation or systemic alkalosis were not attempted.

RESULTS: Mean duration of ventilation was 9.9±14 days (median 6.5 days). Average mean airway pressure (MAP) dropped from 17.7±4.3 cm H2O at the referral hospital to 13.2±2.5 cm H2O (p<0.001) following admission to our unit using conventional settings and GV, before starting INO. Mean oxygenation index (OI) dropped from 46.8±24.5 to 22.7±21.4 within 24 hours of INO therapy (p<0.001). Infants with higher baseline pH and lower baseline OI responded better to INO (p<0.02). Overall survival was 72%. Patients with MAS and PPHN had the best response, 92% survived and there was a 46% reduction in need for extracorporeal membrane oxygenation (ECMO) compared to historical pre-INO period controls (23.9% vs. 12.8%, p<0.01). In the infants treated with GV alone, the MAP dropped from 17.2±4.3 cm H2O at the referral hospital to 12.6±2.4 after GV was started in our unit.

CONCLUSIONS: We conclude that INO is an effective and well-tolerated therapy for PH in infants receiving GV.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3

Similar content being viewed by others

References

  1. Gersony WM, Duc GV, Sinclair JC . PFC syndrome (persistence of the fetal circulation) Circulation 1969 40: Suppl 3 87

    Google Scholar 

  2. Walsh-Sukys MC, Cornell DJ, Houston LN, Keszler M, Kanto WP Jr . Treatment of persistent pulmonary hypertension of the newborn without hyperventilation: an assessment of diffusion of innovation Pediatrics 1994 Sep 94: 3 303–6

    CAS  PubMed  Google Scholar 

  3. Fox WW, Duara S . Persistent pulmonary hypertension in the neonate: diagnosis and management J Pediatr 1983 103: 505–14

    Article  CAS  Google Scholar 

  4. Weigel TJ, Hageman JR . National survey of diagnosis and management of persistent pulmonary hypertension of the newborn J Perinatol 1990 10: 369–75

    CAS  PubMed  Google Scholar 

  5. Roberts JD Jr, Chen T, Kawai N et al. Inhaled nitric oxide reverses pulmonary vasoconstriction in the hypoxic and acidotic newborn lamb Circ Res 1993 72: 246–54

    Article  CAS  Google Scholar 

  6. Davidson D, Barefield E, Kattwinkel J et al. Inhaled nitric oxide for the early treatment of persistent pulmonary hypertension of the term newborn; a randomized double-masked, placebo-controlled, dose–response, multicenter study, the I-NO/PPHN Study Group Pediatrics 1998 Mar 101: 3 Pt 1 325–34

    Article  CAS  Google Scholar 

  7. Kinsella JP, Abman SH . Clinical pathophysiology of persistent pulmonary hypertension of the newborn and the role of inhaled nitric oxide therapy J Perinatol 1996 Mar 16: 2 Pt 2 Su S24–7

    CAS  PubMed  Google Scholar 

  8. The Neonatal Inhaled Nitric Oxide Study Group . Inhaled nitric oxide in full-term and nearly full-term infants with hypoxic respiratory failure N Engl J Med 1997 Feb 27 336: 9 597–604

    Article  Google Scholar 

  9. Kinsella JP, Truog WE, Walsh WF et al. Randomized, multicenter trial of inhaled nitric oxide and high-frequency oscillatory ventilation in severe, persistent pulmonary hypertension of the newborn J Pediatr 1997 Jul 131: 1 Pt 1 55–62

    Article  CAS  Google Scholar 

  10. Clark RH, Kueser TJ, Walker MW et al. Low-dose nitric oxide therapy for persistent pulmonary hypertension of the newborn N Engl J Med 2000 342: 7 469–74

    Article  CAS  Google Scholar 

  11. Fanaroff A, Wright E, Korones S, Wright L . Center variability: an inherent component of multicenter clinical trials — advantage or disadvantage Pediatr Res 1992 31: 246A (Abstract)

    Google Scholar 

  12. Wung JT, James LS, Kilchevsky, James E . Management of infants with severe respiratory failure and persistence of fetal circulation, without hyperventilation Pediatrics 1985 76: 488–94

    CAS  PubMed  Google Scholar 

  13. Marron MJ, Crisafi MA, Driscoll JD et al. Hearing and neurodevelopmental outcome in survivors of persistent pulmonary hypertension of the newborn Pediatrics 1992 90: 3 392–6

    CAS  PubMed  Google Scholar 

  14. Sahni R, Wung J-T, James LS . Controversies in the management of persistent pulmonary hypertension of the newborn Pediatrics 1994 94: 3 307–9

    CAS  PubMed  Google Scholar 

  15. Wung J-T . Mechanical ventilation using conventional infant respirators In: Pomerance JJ, Richardson CJ, editors Neonatology for the Clinician Norwalk, CT: Appleton & Lange 1993 p 279–87

    Google Scholar 

  16. Goldman AP, Tasker RC, Haworth SG, Sigston PE, Macrae DJ . Four patterns of response to inhaled nitric oxide therapy for persistent pulmonary hypertension of the newborn Pediatrics 1996 Oct 98: 4 706–13

    CAS  PubMed  Google Scholar 

  17. Aly H, Sahni R, Wung JT . Weaning strategy with inhaled nitric oxide treatment in persistent pulmonary hypertension of the newborn Arch Dis Child Fetal Neonatal Ed 1997 Mar 76: 2 F118–22

    Article  CAS  Google Scholar 

  18. Kennealy JA, McLennan JE, Loudon RG, McLaurin RL . Hyperventilation-induced cerebral hypoxia Am Rev Respir Dis 1980 122: 407–12

    CAS  PubMed  Google Scholar 

  19. Wiswell TE, Graziani LJ, Kornhauser MS, Merton DA, McKee L, Spitzer AR . Effects of hypocarbia on the development of cystic periventricular leukomalacia in premature infants treated with high-frequency jet ventilation Pediatrics 1996 Nov 98: 5 918–24

    CAS  PubMed  Google Scholar 

  20. Naulty CM, Weiss IP, Herer GR . Progressive sensorineural hearing loss in survivors of persistent fetal circulation Ear Hear 1986 7: 74–7

    Article  CAS  Google Scholar 

  21. Tooley WH . Epidemiology of bronchopulmonary dysplasia J Pediatr 1979 95: 851–5

    Article  CAS  Google Scholar 

  22. West JB . Respiratory physiology: the essentials 3rd ed Baltimore, MD: Williams & Wilkins 1985 p 31–48

    Google Scholar 

  23. Short BL, Pearson GD . Neonatal extracorporeal membrane oxygenation. A review J Intens Care Med 1986 1: 47–54

    Article  Google Scholar 

  24. Boloker J, Bateman DA, Wung JT, Stolar CJ . Congenital diaphragmatic hernia in 120 infants treated consecutively with permissive hypercapnia/spontaneous respiration/elective repair J Pediatr Surg 2002 Mar 37: 3 357–66

    Article  Google Scholar 

  25. Aly H, Bhutada A, Sahni R, Wung JT . Inhaled nitric oxide (INO) decreases the need for extracorporeal membrane oxygenation (ECMO) in neonates with meconium aspiration syndrome (MAS) Pediatr Res 1996 34: 4 324A–1926

    Google Scholar 

  26. Rosenberg AA, Kennaugh JM, Moreland SG et al. Longitudinal follow-up of newborn infants treated with inhaled nitric oxide for persistent pulmonary hypertension J Pediatr 1997 131: 70–5

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We would like to acknowledge Richard Polin, MD for his editorial assistance.

Author information

Authors and Affiliations

  1. Department of Pediatrics, The Children's Hospital of New York, College of Physicians and Surgeons, Columbia University, New York, NY, USA

    Anju Gupta MD, MRCP, Shantanu Rastogi MD, Rakesh Sahni MD, Alok Bhutada MD, David Bateman MD, Deepa Rastogi MD, Arthur Smerling MD & Jen-Tien Wung MD

  2. Department of Anesthesiology, The Children's Hospital of New York, College of Physicians and Surgeons, Columbia University, New York, NY, USA

    Arthur Smerling MD & Jen-Tien Wung MD

Authors
  1. Anju Gupta MD, MRCP
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Shantanu Rastogi MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Rakesh Sahni MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Alok Bhutada MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. David Bateman MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Deepa Rastogi MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Arthur Smerling MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Jen-Tien Wung MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gupta, A., Rastogi, S., Sahni, R. et al. Inhaled Nitric Oxide and Gentle Ventilation in the Treatment of Pulmonary Hypertension of the Newborn — a Single-Center, 5-Year Experience. J Perinatol 22, 435–441 (2002). https://doi.org/10.1038/sj.jp.7210761

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.jp.7210761

This article is cited by

Search

Advanced search

Quick links